Astrid Sissel Jørgensen

CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells

Astrid Sissel Jørgensen, Pontian E Adogamhe, Julia M. Laufer et al. · Journal of Leukocyte Biology · 2018 · 40 citations · Full text

Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization

Astrid Sissel Jørgensen, Viktorija Daugvilaite, Katia De Filippo et al. · Communications Biology · 2021 · 40 citations · Full text

Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7

Astrid Sissel Jørgensen, Olav Larsen, Edith Uetz‐von Allmen et al. · Frontiers in Immunology · 2019 · 29 citations · Full text

The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus

Astrid Sissel Jørgensen, Emma Probst Brandum, Jeppe Malthe Mikkelsen et al. · Cellular and Molecular Life Sciences · 2021 · 22 citations · Full text

Inhibition of HIV Fusion by Small Molecule Agonists through Efficacy-Engineering of CXCR4

Christian Berg, Viktorija Daugvilaite, Anne Steen et al. · ACS Chemical Biology · 2018 · 11 citations